Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression.
Kemp Bohan PM, Chick RC, O'Shea AE, Vreeland TJ, Hickerson AT, Cindass JL, Ensley DC, Hale D, Clifton GT, Sohn VY, Thompson IM Jr, Peoples GE, Liss MA. Kemp Bohan PM, et al. Among authors: hickerson at. Cancer Prev Res (Phila). 2021 May;14(5):551-562. doi: 10.1158/1940-6207.CAPR-20-0383. Epub 2021 Jan 29. Cancer Prev Res (Phila). 2021. PMID: 33514567 Clinical Trial.
Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer.
Clifton GT, Hale D, Vreeland TJ, Hickerson AT, Litton JK, Alatrash G, Murthy RK, Qiao N, Philips AV, Lukas JJ, Holmes JP, Peoples GE, Mittendorf EA. Clifton GT, et al. Among authors: hickerson at. Clin Cancer Res. 2020 Jun 1;26(11):2515-2523. doi: 10.1158/1078-0432.CCR-19-2741. Epub 2020 Feb 18. Clin Cancer Res. 2020. PMID: 32071118 Free PMC article. Clinical Trial.
Chemoprevention in familial adenomatous polyposis: past, present and future.
Kemp Bohan PM, Mankaney G, Vreeland TJ, Chick RC, Hale DF, Cindass JL, Hickerson AT, Ensley DC, Sohn V, Clifton GT, Peoples GE, Burke CA. Kemp Bohan PM, et al. Among authors: hickerson at. Fam Cancer. 2021 Jan;20(1):23-33. doi: 10.1007/s10689-020-00189-y. Epub 2020 Jun 8. Fam Cancer. 2021. PMID: 32507936 Free PMC article. Review.
Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.
Kemp Bohan PM, Chick RC, Hickerson AT, Messersmith LM, Williams GM, Cindass JL, Lombardo J, Collins R, Brady RO, Hale DF, Peoples GE, Vreeland TJ, Clifton GT. Kemp Bohan PM, et al. Among authors: hickerson at. Cancer Immunol Immunother. 2021 May;70(5):1465-1474. doi: 10.1007/s00262-020-02784-5. Epub 2020 Nov 12. Cancer Immunol Immunother. 2021. PMID: 33180182 Free PMC article.
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
Chick RC, Clifton GT, Hale DF, Vreeland TJ, Hickerson AT, Kemp Bohan PM, McCarthy PM, Litton JK, Alatrash G, Murthy RK, Qiao N, Philips A, Lukas J, Holmes JP, Mittendorf EA, Peoples GE. Chick RC, et al. Among authors: hickerson at. Clin Immunol. 2021 Apr;225:108679. doi: 10.1016/j.clim.2021.108679. Epub 2021 Jan 22. Clin Immunol. 2021. PMID: 33485895 Clinical Trial.
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.
Vreeland TJ, Clifton GT, Hale DF, Chick RC, Hickerson AT, Cindass JL, Adams AM, Bohan PMK, Andtbacka RHI, Berger AC, Jakub JW, Sussman JJ, Terando AM, Wagner T, Peoples GE, Faries MB. Vreeland TJ, et al. Among authors: hickerson at. Ann Surg Oncol. 2021 Oct;28(11):6126-6137. doi: 10.1245/s10434-021-09709-1. Epub 2021 Feb 27. Ann Surg Oncol. 2021. PMID: 33641012 Free PMC article. Clinical Trial.
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.
Chick RC, Faries MB, Hale DF, Kemp Bohan PM, Hickerson AT, Vreeland TJ, Myers JW 3rd, Cindass JL, Brown TA 2nd, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Clifton GT, Park H, Sloan AJ, Wagner T, Peoples GE. Chick RC, et al. Among authors: hickerson at. Cancer Med. 2021 Jul;10(13):4302-4311. doi: 10.1002/cam4.3969. Epub 2021 May 12. Cancer Med. 2021. PMID: 33982452 Free PMC article. Clinical Trial.
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma.
Adams AM, Chick RC, Vreeland TJ, Clifton GT, Hale DF, McCarthy PM, O'Shea AE, Bohan PMK, Hickerson AT, Park H, Sloan AJ, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Wagner T, Faries MB, Peoples GE. Adams AM, et al. Among authors: hickerson at. Melanoma Res. 2021 Aug 1;31(4):378-388. doi: 10.1097/CMR.0000000000000758. Melanoma Res. 2021. PMID: 34193804
Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.
O'Shea AE, Valdera FA, Ensley D, Smolinsky TR, Cindass JL, Kemp Bohan PM, Hickerson AT, Carpenter EL, McCarthy PM, Adams AM, Vreeland TJ, Clifton GT, Peoples GE. O'Shea AE, et al. Among authors: hickerson at. Clin Immunol. 2022 Dec;245:109095. doi: 10.1016/j.clim.2022.109095. Epub 2022 Aug 13. Clin Immunol. 2022. PMID: 35973640 Review.
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.
Adams AM, Carpenter EL, Clifton GT, Vreeland TJ, Chick RC, O'Shea AE, McCarthy PM, Kemp Bohan PM, Hickerson AT, Valdera FA, Tiwari A, Hale DF, Hyngstrom JR, Berger AC, Jakub JW, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries MB, Peoples GE. Adams AM, et al. Among authors: hickerson at. Cancer Immunol Immunother. 2023 Mar;72(3):697-705. doi: 10.1007/s00262-022-03272-8. Epub 2022 Sep 1. Cancer Immunol Immunother. 2023. PMID: 36045304 Free PMC article. Clinical Trial.
13 results